These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy. Pleger ST; Boucher M; Most P; Koch WJ J Card Fail; 2007 Jun; 13(5):401-14. PubMed ID: 17602988 [TBL] [Abstract][Full Text] [Related]
5. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure. Koch WJ Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162 [TBL] [Abstract][Full Text] [Related]
6. Potential future therapies for heart failure: gene transfer of beta-adrenergic signaling components. Maurice JP; Koch WJ Coron Artery Dis; 1999 Sep; 10(6):401-5. PubMed ID: 10474791 [TBL] [Abstract][Full Text] [Related]
7. Genetic editing of dysfunctional myocardium. Hajjar RJ; Huq F; Matsui T; Rosenzweig A Med Clin North Am; 2003 Mar; 87(2):553-67. PubMed ID: 12693739 [TBL] [Abstract][Full Text] [Related]
8. Targeting phospholamban by gene transfer in human heart failure. del Monte F; Harding SE; Dec GW; Gwathmey JK; Hajjar RJ Circulation; 2002 Feb; 105(8):904-7. PubMed ID: 11864915 [TBL] [Abstract][Full Text] [Related]
9. Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure. Dieterle T; Meyer M; Gu Y; Belke DD; Swanson E; Iwatate M; Hollander J; Peterson KL; Ross J; Dillmann WH Cardiovasc Res; 2005 Sep; 67(4):678-88. PubMed ID: 15927173 [TBL] [Abstract][Full Text] [Related]
10. Inotropy, calcium, and heart failure: a personal perspective. Schwartz A Am J Cardiol; 1999 Jun; 83(12A):86H-88H. PubMed ID: 10750594 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy for the treatment of heart failure--calcium signaling. Bernecker OY; del Monte F; Hajjar RJ Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):268-76. PubMed ID: 12973704 [TBL] [Abstract][Full Text] [Related]